We examined adults with untreated Burkitt lymphoma (BL) from 2009 to 2018 across 30 US
cancer centers. Factors associated with progression-free survival (PFS) and overall survival …

Burkitt lymphoma (BL) is a highly aggressive B-cell non-Hodgkin lymphoma characterized
by marked tumor proliferation resulting from translocation of the MYC oncogene. Distinct …

Genomic studies have revealed molecular mechanisms involved in the pathogenesis of
Burkitt's lymphoma, including the ID3/TCF3-dependent centroblast gene expression …

Abstract Purpose of Review Cancer remains a major cause of morbidity and mortality in HIV-
infected individuals, with aggressive non-Hodgkin's lymphoma as the most frequent one …

In January 2020, the first documented patient in the United States infected with severe acute
respiratory syndrome coronavirus 2 was diagnosed in Washington State. Since that time …

Treatment of Burkitt lymphoma (BL) with intensive, multi‐agent chemotherapy with
aggressive central nervous system (CNS) prophylaxis results in high cure rates, although no …

Non‐endemic Burkitt lymphoma (BL) is a rare germinal centre B‐cell‐derived malignancy
with the genetic hallmark of MYC gene translocation and with rapid tumour growth as a …

Background Although the increased use of combined antiretroviral therapy (cART) has
decreased the incidence of lymphomas HIV-associated, Burkitt lymphoma (BL) incidence …

The 2016 World Health Organization (WHO) classification has designated two categories of
high-grade B-cell lymphoma (HGBCL): HGBCL with MYC and BLC2 and/or BCL6 …

Introduction Outcomes after frontline treatment of Burkitt lymphoma (BL) have improved with
the introduction of dose‐intense chemotherapy regimens, such as CODOX‐M/IVAC. While …